Literature DB >> 20692406

Culture of impure human islet fractions in the presence of alpha-1 antitrypsin prevents insulin cleavage and improves islet recovery.

G Loganathan1, R K Dawra, S Pugazhenthi, A C Wiseman, M A Sanders, A K Saluja, D E R Sutherland, B J Hering, A N Balamurugan.   

Abstract

BACKGROUND: Exocrine tissue is commonly cotransplanted with islets in autografting and allotransplantation of impure preparations. Proteases and insulin are released by acinar cells and islets, respectively, during pretransplantation culture and also systemically after transplantation. We hypothesized that released proteases could cleave insulin molecules and that addition of alpha-1 antitrypsin (A1AT) to impure islet cultures would block this cleavage, improving islet recovery and function.
METHODS: Trypsin, chymotrypsin, and elastase (TCE) activity and insulin levels were measured in culture supernates of pure (n = 5) and impure (n = 5) islet fractions, which were isolated from deceased donors. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to detect insulin after incubation with proteases. We assessed the effects of A1AT supplementation (0.5 mg/mL; n = 4] on TCE activity, insulin levels, culture recovery, and islet quality. The ultrastructure of islets exposed to TCE versus control medium was examined using electron microscopy (EM).
RESULTS: Protease (TCE) activity in culture supernatants was indirectly proportional to the percentage purity of islets: pure, impure, or highly impure. Increasingly lower levels of insulin were detected in culture supernatants when higher protease activity levels were present. Insulin levels measured from supernatants of impure and highly impure islet preparations were 61 +/- 23.7% and 34 +/- 33% of that in pure preparations, respectively. Incubation with commercially available proteases (TCE) or exocrine acinar cell supernatant cleaved insulin molecules as assessed using SDS-PAGE. Addition of A1AT to impure islet preparations reduced protease activity and restored normal insulin levels as detected using enzyme-linked immunosorbent assay (ELISA) and SDS-PAGE of culture supernates. A1AT improved insulin levels to 98% +/- 1.3% in impure and 78% +/- 34.2% in highly impure fractions compared with pure islet fractions. A1AT supplementation improved postculture recovery of islets in impure preparations compared with nontreated controls (72% +/- 9% vs 47% +/- 15%). Islet viability as measured using membrane integrity assays was similar in both the control (98% +/- 2%) and the A1AT-treated groups (99% +/- 1%). EM results revealed a reduction or absence of secretory granules after exposure to proteases (TCE).
CONCLUSION: Culture of impure human islet fractions in the presence of A1AT prevented insulin cleavage and improved islet recovery. A1AT supplementation of islet culture media, therefore, may increase the proportion of human islet products that meet release criteria for transplantation. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20692406      PMCID: PMC2924667          DOI: 10.1016/j.transproceed.2010.05.119

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  Successful human islet isolation and transplantation indicating the importance of class 1 collagenase and collagen degradation activity assay.

Authors:  A N Balamurugan; Andrew G Breite; Takayuki Anazawa; Gopalakrishnan Loganathan; Joshua J Wilhelm; Klearchos K Papas; Francis E Dwulet; Robert C McCarthy; Bernhard J Hering
Journal:  Transplantation       Date:  2010-04-27       Impact factor: 4.939

2.  Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin.

Authors:  S Kawabata; T Miura; T Morita; H Kato; K Fujikawa; S Iwanaga; K Takada; T Kimura; S Sakakibara
Journal:  Eur J Biochem       Date:  1988-02-15

3.  alpha-1-Antitrypsin immunoreactivity in islet cells of adult human pancreas.

Authors:  M B Ray; V J Desmet; W Gepts
Journal:  Cell Tissue Res       Date:  1977-11-30       Impact factor: 5.249

4.  2008 Update from the Collaborative Islet Transplant Registry.

Authors:  Rodolfo Alejandro; Franca B Barton; Bernhard J Hering; Steve Wease
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

  4 in total
  11 in total

Review 1.  Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes.

Authors:  Gabriella Fleixo-Lima; Hilla Ventura; Michal Medini; Liliana Bar; Pnina Strauss; Eli C Lewis
Journal:  J Diabetes Sci Technol       Date:  2014-08-25

2.  Detailed protocol for evaluation of dynamic perifusion of human islets to assess β-cell function.

Authors:  Kwamina Bentsi-Barnes; Máire E Doyle; Danny Abad; Fouad Kandeel; Ismail Al-Abdullah
Journal:  Islets       Date:  2011-09-01       Impact factor: 2.694

3.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

4.  An islet maturation media to improve the development of young porcine islets during in vitro culture.

Authors:  Hien Lau; Nicole Corrales; Samuel Rodriguez; Colleen Luong; Frank Zaldivar; Michael Alexander; Jonathan R T Lakey
Journal:  Islets       Date:  2020-05-27       Impact factor: 2.694

5.  Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment.

Authors:  Gopalakrishnan Loganathan; Rajinder K Dawra; Subbiah Pugazhenthi; Zhiguang Guo; Sajjad M Soltani; Alexander Wiseman; Mark A Sanders; Klearchos K Papas; Kumaravel Velayutham; Ashok K Saluja; David E R Sutherland; Bernhard J Hering; A N Balamurugan
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

6.  Human Pancreatic Acinar Cells: Proteomic Characterization, Physiologic Responses, and Organellar Disorders in ex Vivo Pancreatitis.

Authors:  Aurelia Lugea; Richard T Waldron; Olga A Mareninova; Natalia Shalbueva; Nan Deng; Hsin-Yuan Su; Diane D Thomas; Elaina K Jones; Scott W Messenger; Jiayue Yang; Cheng Hu; Ilya Gukovsky; Zhenqiu Liu; Guy E Groblewski; Anna S Gukovskaya; Fred S Gorelick; Stephen J Pandol
Journal:  Am J Pathol       Date:  2017-09-19       Impact factor: 4.307

Review 7.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

8.  Immune protective effect of human alpha-1-antitrypsin gene during β cell transplantation in diabetic mice.

Authors:  Lu Yang; Yu-Ting Liao; Xiao-Fei Yang; Li-Wei Reng; Hui Qi; Fu-Rong Li
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

9.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15

10.  Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.

Authors:  Efrat Ashkenazi; Boris M Baranovski; Galit Shahaf; Eli C Lewis
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.